Retracted: Efficacy Investigation of TACE Combined with Lenvatinib and Sintilimab in Intermediate-Stage Hepatocellular Carcinoma

Detalles Bibliográficos
Autor principal: Markers, Disease
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396735/
https://www.ncbi.nlm.nih.gov/pubmed/37538090
http://dx.doi.org/10.1155/2023/9791613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396735/
https://www.ncbi.nlm.nih.gov/pubmed/37538090
http://dx.doi.org/10.1155/2023/9791613

Ejemplares similares